U.S. markets open in 7 hours 24 minutes

Altimmune, Inc. (ALT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
8.87+0.65 (+7.91%)
At close: 04:00PM EST
8.95 +0.08 (+0.90%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close8.22
Bid0.00 x 800
Ask0.00 x 1000
Day's Range8.07 - 8.93
52 Week Range2.09 - 12.99
Avg. Volume12,266,616
Market Cap476.575M
Beta (5Y Monthly)-0.00
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJan 20, 2017
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ALT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Altimmune, Inc.
    DVAX: What does Argus have to say about DVAX?DYNAVAX TECHNOLOGIES CORP has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • TipRanks

    These 2 ‘Strong Buy’ Penny Stocks Could Soar to $25 (Or Higher), Says Piper Sandler

    Whether you love them or hate them, penny stocks are contentious. These tickers, which trade for less than $5 per share, have earned a reputation on Wall Street for their divisive nature, leaving investors struggling to find common ground on the matter. The appeal is clear. For the same price as one share of a more well-known company, investors can snap up hundreds of shares of a penny stock. What’s more, the fact that even minor share price appreciation can translate to irresistible percentage